IceCure Medical Ltd (ICCM)
NASDAQ: ICCM · Real-Time Price · USD
5.96
-1.06 (-15.10%)
At close: Jun 26, 2026, 4:00 PM EDT
5.83
-0.13 (-2.18%)
After-hours: Jun 26, 2026, 7:59 PM EDT
IceCure Medical Stock Forecast
ICCM's stock price has decreased by -80.52% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for IceCure Medical stock have an average target of 44.5, with a low estimate of 30 and a high estimate of 73.5. The average target predicts an increase of 646.64% from the current stock price of 5.96.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for IceCure Medical stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Mar '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Brookline Capital Markets | Brookline Capital Markets | Buy Maintains $74 | Buy | Maintains | $74 | +1,133.22% | Jun 17, 2026 |
| Maxim Group | Maxim Group | Buy Maintains $90 → $30 | Buy | Maintains | $90 → $30 | +403.36% | May 14, 2026 |
| Alliance Global Partners | Alliance Global Partners | Buy Maintains $30 | Buy | Maintains | $30 | +403.36% | May 13, 2026 |
Financial Forecast
Revenue This Year
6.37M
from 3.38M
Increased by 88.51%
Revenue Next Year
12.55M
from 6.37M
Increased by 96.95%
EPS This Year
-4.76
from -7.20
EPS Next Year
-2.51
from -4.76
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 9.7M | 18.3M | |
| Avg | 6.4M | 12.5M | |
| Low | 4.4M | 6.9M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 186.5% | 187.6% | |
| Avg | 88.5% | 97.0% | |
| Low | 31.0% | 7.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -3.51 | -2.02 | |
| Avg | -4.76 | -2.51 | |
| Low | -6.00 | -3.00 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.